trial · primary record
Rimegepant (PF-07899801)
Acute Treatment of Migraine
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 600 |
| Primary completion | 2030-07-31 |
| Primary endpoint | The frequency and severity of on-treatment and treatment-emergent adverse events, serious adverse events, adverse events leading to discontinuation, clinically significant lab abnormalities |
| Registry ID | NCT04743141 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:43.387Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04743141
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.